Danish Prime Minister Mette Frederiksen said she’s “extremely proud” of the country’s corporate champions, and rejected ...
The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...
Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...
On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 ...
Denmark stocks were lower after the close on Monday, as losses in the Healthcare, Chemicals and Personal & Household Goods ...
The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.
Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...
(Reuters) - Novo Nordisk (NYSE: NVO )'s blockbuster diabetes drug Ozempic will be eligible for U.S. government's price ...